Literature DB >> 12581330

Pediatric cardiac transplant: results using a steroid-free maintenance regimen.

H Leonard1, T Hornung, G Parry, J H Dark.   

Abstract

We report on survival, rejection, lymphoma and renal function following cardiac transplant using a steroid-free maintenance immunosuppressive regimen. We have performed 73 cardiac transplants in 71 children under 16 yr of age in the last 12 yr. There were eight perioperative and four late deaths giving actuarial survival of 88, 88, 85 and 70% at 1, 2, 5 and 10 yr, respectively. A total of 11 (15.3%) children had one episode of rejection (grade 3) in the first 6 months; one died and one was re-transplanted because of rejection. There was only one episode of late rejection (8 yr post-transplant) because of low drug levels in a patient with lymphoma and sepsis. This patient did not survive. Three other children (5.6%) also developed lymphoma and recovered but one died subsequently of graft failure. Four children have developed severe renal failure (glomerular filtration rate GFR <30 mL/min/m2). Two have not survived and one is expected to commence dialysis soon. The remainder have mild to moderate renal impairment. We report excellent survival and low rejection rates without use of long-term steroids. However the doses of cyclosporin used have had a significant effect on renal function in many cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581330     DOI: 10.1034/j.1399-3046.2003.00014.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  10 in total

1.  Steroid avoidance in pediatric heart transplantation results in excellent graft survival.

Authors:  Scott R Auerbach; Jane Gralla; David N Campbell; Shelley D Miyamoto; Biagio A Pietra
Journal:  Transplantation       Date:  2014-02-27       Impact factor: 4.939

Review 2.  Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.

Authors:  Troels K Bergmann; Katherine A Barraclough; Katie J Lee; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

3.  Immunosuppression therapy for pediatric heart transplantation.

Authors:  Claire A Irving; Steven A Webber
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-10

Review 4.  Steroid-free immunosuppression in organ transplantation.

Authors:  Gaoxing Luo; Edward M Falta; Eric A Elster
Journal:  Curr Diab Rep       Date:  2005-08       Impact factor: 4.810

5.  Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients.

Authors:  Tajinder P Singh; Carey Faber; Elizabeth D Blume; Sarah Worley; Christopher S Almond; Leslie B Smoot; Shay Dillis; Colleen Nasman; Gerard J Boyle
Journal:  J Heart Lung Transplant       Date:  2010-01-12       Impact factor: 10.247

Review 6.  Strategies to prevent cellular rejection in pediatric heart transplant recipients.

Authors:  Susan W Denfield
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022

Review 7.  Postoperative care of the transplanted patient.

Authors:  Kurt R Schumacher; Robert J Gajarski
Journal:  Curr Cardiol Rev       Date:  2011-05

Review 8.  Peri-operative kidney injury and long-term chronic kidney disease following orthotopic heart transplantation in children.

Authors:  Aparna Hoskote; Michael Burch
Journal:  Pediatr Nephrol       Date:  2014-08-14       Impact factor: 3.714

Review 9.  Steroid-free and steroid withdrawal protocols in heart transplantation: the review of literature.

Authors:  Massimo Baraldo; Giorgia Gregoraci; Ugolino Livi
Journal:  Transpl Int       Date:  2014-04-12       Impact factor: 3.782

Review 10.  A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients.

Authors:  Martin Schweiger; Andreas Zuckermann; Andres Beiras-Fernandez; Michael Berchtolld-Herz; Udo Boeken; Jens Garbade; Stephan Hirt; Manfred Richter; Arjang Ruhpawar; Jan Dieter Schmitto; Felix Schönrath; Rene Schramm; Uwe Schulz; Markus J Wilhelm; Markus J Barten
Journal:  Ann Transplant       Date:  2018-05-15       Impact factor: 1.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.